题名

非侵入性肝功能指標在評估肝癌預後所扮演的角色

DOI

10.6666/ClinMed.201810_82(4).0110

作者

何樹仁；霍德義

关键词

肝癌(hepatocellular carcinoma, HCC) ； 非侵入性肝功能指標(noninvasive liver functional reserve models)

期刊名称

臨床醫學月刊

卷期/出版年月

82卷4期（2018 / 10 / 26）

页次

601 - 604

内容语文

繁體中文
中文摘要

肝癌是臺灣癌症死亡的第二大原因，每年約有7,000名患者死於肝癌。肝功能或肝纖維惡化嚴重程度對於肝癌病患者的預後及治療有巨大影響。近年來非侵入性肝功能指標可應用於評估肝癌患者的肝功能或肝纖維化程度，減少因侵入性檢查造成之併發症，本文將介紹非侵入性肝功能指標在評估肝癌預後所扮演的角色。根據多中心研究(multicenter trial)結果，肝癌患者接受不同的治療，ALBI grade 最能客觀預測肝癌患者的預後。
主题分类 醫藥衛生 > 基礎醫學
醫藥衛生 > 社會醫學
参考文献
  1. Bruix, J,Sherman, M(2011).Management of hepatocellular carcinoma: an update.Hepatology,53,1020-1022.
  2. European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer(2012).EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.J Hepatol,56,908-943.
  3. Ho, SY,Liu, PH,Hsu, CY(2017).Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.PloS One,12,e0180408.
  4. Huo, TI,Lee, PC,Huang, YH(2006).The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapy.J Clin Gastroenterol,40,543-550.
  5. Johnson, PJ,Berhane, S,Kagebayashi, C(2015).Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.J Clin Oncol,33,550-558.
  6. Liu, PH,Hsu, CY,Hsia, CY(2017).ALBI and PALBI Grade Predict Survival for HCC across Treatment Modalities and BCLC Stages in the MELD Era.J Gastroenterol Hepatol,32,879-886.
  7. Parkin, DM,Bray, F,Ferlay, J(2005).Global cancer statistics, 2002.CA: Cancer J Clin,55,74-108.
  8. Pinato, DJ,Sharma, R,Allara, E(2017).The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.J Hepatol,66,338-346.
  9. Vallet-Pichard, A,Mallet, V,Nalpas, B(2007).FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.Hepatology,46,32-36.
  10. Wai, CT,Greenson, JK,Fontana, RJ(2003).A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.Hepatology,38,518-526.
print cancel